open access

Vol 8, No 6 (2019)
REVIEW ARTICLES
Published online: 2020-01-23
Get Citation

Review of nuclear medicine methods applied in diabetology

Paulina Cegła, Dorota Pisarczyk-Wiza, Krzysztof Matuszewski, Kamila Witkowska, Natalia Bocer, Katarzyna Pietrasz, Aleksandra Kaczmarek, Dorota Zozulińska-Ziółkiewicz
DOI: 10.5603/DK.2019.0028
·
Clinical Diabetology 2019;8(6):303-309.

open access

Vol 8, No 6 (2019)
REVIEW ARTICLES
Published online: 2020-01-23

Abstract

The aim of this paper is to present the most relevant clinical applications of positron emission tomography/computed tomography, scintigraphy and single photon emission tomography with different radiotracers allowing to visualize e.g. glucose metabolism, amino acids metabolism, receptor density or inflammation and infections in diabetology.

Abstract

The aim of this paper is to present the most relevant clinical applications of positron emission tomography/computed tomography, scintigraphy and single photon emission tomography with different radiotracers allowing to visualize e.g. glucose metabolism, amino acids metabolism, receptor density or inflammation and infections in diabetology.

Get Citation

Keywords

diabetology, positron emission tomography, nuclear medicine, inflammation, scintigraphy

About this article
Title

Review of nuclear medicine methods applied in diabetology

Journal

Clinical Diabetology

Issue

Vol 8, No 6 (2019)

Pages

303-309

Published online

2020-01-23

DOI

10.5603/DK.2019.0028

Bibliographic record

Clinical Diabetology 2019;8(6):303-309.

Keywords

diabetology
positron emission tomography
nuclear medicine
inflammation
scintigraphy

Authors

Paulina Cegła
Dorota Pisarczyk-Wiza
Krzysztof Matuszewski
Kamila Witkowska
Natalia Bocer
Katarzyna Pietrasz
Aleksandra Kaczmarek
Dorota Zozulińska-Ziółkiewicz

References (46)
  1. https://stat gov pl/infografiki-widzety/infografiki/infografika-swiatowy-dzien-walki-z-cukrzyca-14-listopada,46,2 html. (odwiedzone 21.04.2019).
  2. Almakiewiz R, Szostak S, Birkenfeld B. Podstawy fizyki promieniowania. In: Birkenfeld B, Listewnik M (ed.). Medycyna nuklearna, obrazowanie molekularne. Wydawnictwo Pomorskiego Uniwersytetu Medycznego w Szczecinie, Szczecin 2011: 152–161.
  3. Wernick MN, Aarsvold JN. Emission tomography. The fundamentals of PET and SPECT. San Diego: Elsevier Academic Press. 2004.
  4. Peleg AY, Weerarathna T, McCarthy JS, et al. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev. 2007; 23(1): 3–13.
  5. Kemper J, Kuijper EJ, Mirck PG, et al. Recovery from rhinocerebral mucormycosis in a ketoacidotic diabetic patient: a case report. J Laryngol Otol. 1993; 107(3): 233–235.
  6. Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin North Am. 2008; 41(3): 537–549.
  7. Bhansali A, Sridhar C, Choudhary S. Type 2 diabetes, emphysematous pyelonephritis and emphsematous cholecystitis. J Assoc Physicians India. 2004; 52: 124.
  8. Sella EJ. Current concepts review: diagnostic imaging of the diabetic foot. Foot Ankle INT. 2009; 30: 568–576.
  9. Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002; 45: 1085–1096.
  10. Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med. 1989; 149: 2262–2266.
  11. Alazraki N, Deries D, Datz F, et al. Value of 24-hour image (four phase bone scan) in assessing osteomyelitis in patients with peripheral vascular disease. J Nucl Med. 1985; 26: 711–717.
  12. Israel O, Gips S, Jerushalmi J, et al. Osteomyelitis and soft-tissue infection: differential diagnosis with 24 hour/4 hour ratio of Tc-99m MDP uptake. Radiology. 1987; 163(3): 725–726.
  13. Blume P, Dey H, Daley L, et al. Diagnosis of pedal osteomyelitis with Tc-99m HMPAO labeled leukocytes. J Foot Ankle Sugr. 1997; 36(2): 120–126.
  14. Devillers A, Garin E, Polard JL, et al. Comparison of Tc-99m-labelled antileukocyte fragment Fab' and Tc-99m-HMPAO leukocyte scintigraphy in the diagnosis of bone and joint infections: a prospective study. Nucl Med Commun. 2000; 21(8): 747–753.
  15. Poirier JY, Garin E, Derrien C, et al. Diagnosis of osteomyelitis in the diabetic foot with 99mTC-HMPAO leukocyte scintigraphy combined with a 99mTc-MDP bone scintigraphy. Diabetes Metab. 2002; 28: 485–490.
  16. Hage FG, Lusa L, Dondi M, et al. IAEA Diabetes Investigators. Exercise stress tests for detecting myocardial ischemia in asymptomatic patients with diabetes mellitus. Am J Cardiol. 2013; 112(1): 14–20.
  17. Farmer AD, Bruckner-Holt C, Schwartz S, et al. Diabetic Gastroparesis: Perspectives From a Patient and Health Care Providers. J Patient Cent Res Rev. 2019; 6(2): 148–157.
  18. Krzyżewska M, Maroszek P, Mrozikiewicz-Rakowska B, et al. Diabetic gastroparesis: do you know how to recognize and effectively treat? Diabet Klin. 2014; 3: 157–166.
  19. Strashun AM, Najatheim M, Goldsmith SJ. Malignant external otitis: Elary scintigraphic detection. Radiology 1984; 150: 541–545.
  20. Birkenfeld B, Kozłowska I, Listewnik M. Badania scyntygraficzne nerek. In: Medycyna nuklerana, obrazowanie molekularne. 90–98.
  21. Rossleigh MA. Scintigraphic imaging in renal infections. Q J Nucl Med Mol Imaging. 2009; 53: 72–77.
  22. Elbl B, Birkenfeld B, Kozłowska I. Badania radioizotopowe przewodu pokarmowego. In: Medycyna nuklerana, obrazowanie molekularne. 69–78.
  23. Kalimi R, Gecelter GR, Caplin D, et al. Diagnosis of acute cholecystitis: sensitivity of sonography, cholescintigraphy and combined sonography-cholescintigraphy. J AM Coll Surg. 2001; 193: 609–613.
  24. Saha G. Physics and radiobiology of nuclear medicine. 2006.
  25. National Research Council and Institute of Medicine. Advancing Nuclear Medicine Through Innovation. Washington: The National Academies Press. 2007.
  26. Fogelman I, Gnanasegaran G, Van de. Radionuclide and hybrid bone imaging. Springer-Verlag, Berlin. 2013.
  27. Antunes P, Ginj M, Zhang H, et al. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging. 2007; 34(7): 982–993.
  28. Dziennik Urzędowy Ministra Zdrowia, Obwieszczenie Ministra Zdrowia z dnia 22 grudnia 2014 w sprawie ogłoszenia wykazu wzorcowych procedur radiologicznych z zakresu medycyny nuklearnej.
  29. Ismail D, Hussain K. Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism. Rev Endocr Metab Disord. 2010; 11(3): 165–169.
  30. Buraczewska M, Brandt A, Kopacz K.E, Myśliwiec M. Znaczenie diagnostyki obrazowej wrodzonego hiperinsulinizmu u rodzeństwa. Endokrynol Ped. 2015; 14: 47–50.
  31. Arnoux JB, Verkarre V, Saint-Martin C, et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis. 2011; 6: 63.
  32. Körner M, Christ E, Wild D, et al. Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications. Front Endocrinol (Lausanne). 2012; 3: 158.
  33. Antwi K, Fani M, Nicolas G, et al. Localization of Hidden Insulinomas with ⁶⁸Ga-DOTA-Exendin-4 PET/CT: A Pilot Study. J Nucl Med. 2015; 56(7): 1075–1078.
  34. Luo Y, Yu M, Pan Q, et al. 68Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake. Eur J Nucl Med Mol Imaging. 2015; 42(3): 531–532.
  35. Luo Y, Pan Q, Yao S, et al. Glucagon-like peptide-1 receptor PET/CT with 68Ga-NOTA-Exendin-4 for detecting localized insulinoma: a prospective cohort study. J Nucl Med. 2016; 57(5): 715–720.
  36. Wiehr S, Warnke P, Rolle AM, et al. New pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection. Oncotarget. 2016; 7(10): 10990–11001.
  37. Romero Pastrana F, Thompson JM, Heuker M, et al. Noninvasive optical and nuclear imaging of Staphylococcus-specific infection with a human monoclonal antibody-based probe. Virulence. 2018; 9(1): 262–272.
  38. Pickett JE, Thompson JM, Sadowska A, et al. Molecularly specific detection of bacterial lipoteichoic acid for diagnosis of prosthetic joint infection of the bone. Bone Res. 2018; 6: 13.
  39. Sellmyer MA, Lee I, Hou C, et al. Bacterial infection imaging with [F]fluoropropyl-trimethoprim. Proc Natl Acad Sci U S A. 2017; 114(31): 8372–8377.
  40. Ocampo IZ, de Queiroz Souza Passos P, Ramirez de Carvalho L, et al. In vitro cytotoxic and genotoxic evaluation of peptides used in nuclear medicine (DOTATATE and Ubiquicidin) in CHO-K1 cells. Cytotechnology. 2016; 68(6): 2301–2310.
  41. Carrasco-Hernandez J, SolÃs-Lara H, Altamirano-Ley J, et al. Measured human dosimetry of 68Ga-DOTA-UBI 29–41, a potential tracer for imaging bacterial infection processes. J Nucl Med. 2016; 57: 1020.
  42. Zhang Z, Ordonez AA, Wang H, et al. Positron Emission Tomography Imaging with 2-[F]F- p-Aminobenzoic Acid Detects Staphylococcus aureus Infections and Monitors Drug Response. ACS Infect Dis. 2018; 4(11): 1635–1644.
  43. Neumann KD, Villanueva-Meyer JE, Mutch CA, et al. Imaging Active Infection in vivo Using D-Amino Acid Derived PET Radiotracers. Sci Rep. 2017; 7(1): 7903.
  44. Petrik M, Zhai C, Haas H, et al. Siderophores for molecular imaging applications. Clin Transl Imaging. 2017; 5(1): 15–27.
  45. Li J, Zheng H, Fodah R, et al. Validation of 2-F-fluorodeoxysorbitol as a potential radiopharmaceutical for imaging bacterial infection in the lung. J Nucl Med. 2018; 59(1): 134–139.
  46. Bini J, Naganawa M, Nabulsi N, et al. Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility of C-(+)-PHNO. J Nucl Med. 2018; 59(8): 1249–1254.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl